AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people
The world may be one step closer to getting a coronavirus jab after Oxford University’s vaccine candidate entered its final stage of tests in the US. UK drug giant AstraZeneca, which owns the rights to the vaccine, said it had enrolled 30,000 American volunteers to take part in its phase three clinical trial. It now means … Read more